Short answer
Acadia Healthcare Company Inc (ACHC) filed an 8-K current report with the SEC on July 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Press release announces Acadia Healthcare’s second-quarter fiscal 2026 operating and financial results.
Acadia Healthcare Company Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Press release announces Acadia Healthcare’s second-quarter fiscal 2026 operating and financial results
- Reporting period ended June 30, 2026
- Detailed results and management commentary available in Exhibit 99.1
Item 7.01 · Regulation FD Disclosure
- Conference call scheduled for Q2 2026 results on July 29, 2026 at 9:00 a.m. Eastern Time
- Exhibit 99.2 slides may contain supplemental operating and financial information for investors
- Webcast and slides available through Acadia’s investor website, with webcast access for thirty days
- Investor focus: Medicaid financing changes under the OBBBA, including work requirements and potential admissions pressure
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $865.8M, approximately flat, but normalized growth 2.8% after supplemental-payment timing
- Reported EPS $0.12 vs $0.33, while Adjusted EPS $0.38 vs $0.83, reflecting significant earnings pressure
- Adjusted EBITDA $149.2M, down 26%, pressured by $28.6M PLGL reserve adjustment and higher liability costs
- Operating cash flow $162.1M, up from $133.5M, with capital expenditures falling to $38.6M from $167.7M
- 2026 guidance raised for Adjusted EBITDA to $590M-$615M and operating cash flow to $350M-$400M, while capex fell to $235M-$255M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Acadia Healthcare Company Inc 8-K filings
Get the next ACHC 8-K as it lands
Follow ACHC for push alerts, or ask the research agent what this filing means.